Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 USD | -3.57% | -14.63% | -45.09% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Financials (USD)
Sales 2024 * | 42.96M | Sales 2025 * | 132M | Capitalization | 716M |
---|---|---|---|---|---|
Net income 2024 * | -397M | Net income 2025 * | -332M | EV / Sales 2024 * | 4.96 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 2.93 x |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-2.28
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | -3.57% | ||
1 week | -14.63% | ||
Current month | -14.63% | ||
1 month | -27.66% | ||
3 months | -49.77% | ||
6 months | -30.41% | ||
Current year | -45.09% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 0 M€ | -4.02% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 11.9 | -3.57% | 697,973 |
24-05-09 | 12.34 | -0.40% | 889,669 |
24-05-08 | 12.39 | -4.55% | 746,842 |
24-05-07 | 12.98 | -2.04% | 785,277 |
24-05-06 | 13.25 | -4.95% | 524,747 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.09% | 743M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- SAGE Stock